Minerva Surgical (UTRS) Stock Price, News & Analysis

Company Overview

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0002
• Volume: 155 shs
• Average Volume: 350 shs
• Market Capitalization: $887.90
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

UTRS Stock Analysis - Frequently Asked Questions

How have UTRS shares performed this year?

Minerva Surgical's stock was trading at $0.0001 at the beginning of the year. Since then, UTRS stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here.

How were Minerva Surgical's earnings last quarter?

Minerva Surgical, Inc. (NASDAQ:UTRS) issued its quarterly earnings data on Wednesday, December, 1st. The company reported ($23.00) EPS for the quarter, missing the consensus estimate of ($8.80) by $14.20. The firm had revenue of $12.51 million for the quarter, compared to the consensus estimate of $12.23 million.

When did Minerva Surgical's stock split?

Minerva Surgical's stock reverse split before market open on Monday, October 2nd 2023. The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Minerva Surgical IPO?

Minerva Surgical (UTRS) raised $100 million in an IPO on Friday, October 22nd 2021. The company issued 6,250,000 shares at a price of $15.00-$17.00 per share.

How do I buy shares of Minerva Surgical?

Shares of UTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Minerva Surgical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Minerva Surgical investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Adobe (ADBE) and CrowdStrike (CRWD).

Company Calendar

• Last Earnings: 12/01/2021
• Today: 5/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:UTRS
• CIK: 1452965
• Web: www.minervasurgical.com
• Phone: 855-646-7874
• Fax: N/A
• Employees: 160
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $51.69 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 8,879,000
• Free Float: 8,124,000
• Market Cap: $887.90
• Optionable: Not Optionable
• Beta: 3.85